NO942550L - Humanproteaseinhibitorvariant av Kunitz-type - Google Patents
Humanproteaseinhibitorvariant av Kunitz-typeInfo
- Publication number
- NO942550L NO942550L NO942550A NO942550A NO942550L NO 942550 L NO942550 L NO 942550L NO 942550 A NO942550 A NO 942550A NO 942550 A NO942550 A NO 942550A NO 942550 L NO942550 L NO 942550L
- Authority
- NO
- Norway
- Prior art keywords
- cys
- amino acid
- phe
- naturally occurring
- asn
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
- Saccharide Compounds (AREA)
- Prostheses (AREA)
- Amplifiers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK9200001 | 1992-01-07 | ||
| PCT/DK1993/000004 WO1993014121A1 (en) | 1992-01-07 | 1993-01-07 | A human kunitz-type protease inhibitor variant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO942550D0 NO942550D0 (no) | 1994-07-06 |
| NO942550L true NO942550L (no) | 1994-09-07 |
Family
ID=8153770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO942550A NO942550L (no) | 1992-01-07 | 1994-07-06 | Humanproteaseinhibitorvariant av Kunitz-type |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5576294A (cs) |
| EP (1) | EP0621871B1 (cs) |
| JP (1) | JP3350549B2 (cs) |
| KR (1) | KR100278036B1 (cs) |
| AT (1) | ATE154938T1 (cs) |
| AU (1) | AU676145B2 (cs) |
| CA (1) | CA2127249A1 (cs) |
| CZ (1) | CZ284911B6 (cs) |
| DE (1) | DE69311893T2 (cs) |
| ES (1) | ES2104121T3 (cs) |
| FI (1) | FI943233A7 (cs) |
| HU (1) | HU218104B (cs) |
| IL (1) | IL104325A (cs) |
| NO (1) | NO942550L (cs) |
| NZ (1) | NZ246569A (cs) |
| PL (1) | PL175422B1 (cs) |
| WO (1) | WO1993014121A1 (cs) |
| ZA (1) | ZA9395B (cs) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060134087A1 (en) * | 1988-09-02 | 2006-06-22 | Dyax Corp. | ITI-D1 Kunitz domain mutants as hNE inhibitors |
| US5455338A (en) * | 1993-11-05 | 1995-10-03 | Zymogenetics, Inc. | DNA encoding novel human kunitz-type inhibitors and methods relating thereto |
| US6057287A (en) | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| EP0737207B1 (en) | 1994-01-11 | 2004-09-22 | Dyax Corporation | Inhibitors of human plasmin derived from the kunitz domains |
| WO1995021601A2 (en) * | 1994-01-11 | 1995-08-17 | Protein Engineering Corporation | Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
| US5795954A (en) * | 1994-03-04 | 1998-08-18 | Genentech, Inc. | Factor VIIa inhibitors from Kunitz domain proteins |
| EP0774001B1 (en) * | 1994-08-05 | 2002-10-16 | Chiron Corporation | Production of tissue factor pathway inhibitor |
| US5589359A (en) * | 1994-08-05 | 1996-12-31 | Chiron Corporation | Chimeric proteins |
| US5786328A (en) * | 1995-06-05 | 1998-07-28 | Genentech, Inc. | Use of kunitz type plasma kallikrein inhibitors |
| US5780265A (en) * | 1995-06-05 | 1998-07-14 | Genentech, Inc. | Kunitz type plasma kallikrein inhibitors |
| US20030199450A1 (en) * | 2001-04-27 | 2003-10-23 | Chiron Corporation | Regulation of cytokine synthesis and release |
| US6242414B1 (en) | 1995-06-07 | 2001-06-05 | Chiron Corporation | Regulation of cytokine synthesis and release |
| US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
| PT891426E (pt) * | 1996-03-11 | 2006-10-31 | Bayer Corp | Bicunina humana |
| US20070140979A1 (en) * | 1998-12-22 | 2007-06-21 | Bayer Aktiengesellschaft | Method for accelerating the rate of mucociliary clearance |
| JP3819239B2 (ja) * | 1998-12-22 | 2006-09-06 | バイエル アクチェンゲゼルシャフト | 粘膜線毛クリアランスの速度を促進する方法 |
| GB9916913D0 (en) * | 1999-07-19 | 1999-09-22 | Natural Enviromental Research | Inhibitor proteins |
| US20040054082A1 (en) * | 2001-12-03 | 2004-03-18 | Bank David H | Toughened polymer blends with improved surface properties |
| DE60333758D1 (de) | 2002-06-07 | 2010-09-23 | Dyax Corp | Prevention und Verringerung von Ischemia |
| US7153829B2 (en) | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
| SI2386310T1 (sl) | 2002-08-28 | 2019-03-29 | Dyax Corp. | Metode za ohranjanje organov in tkiv |
| JP2007524348A (ja) * | 2003-01-07 | 2007-08-30 | ダイアックス、コープ | クニッツドメインライブラリー |
| US6989369B2 (en) | 2003-02-07 | 2006-01-24 | Dyax Corp. | Kunitz domain peptides |
| JP4739207B2 (ja) * | 2003-08-29 | 2011-08-03 | ダイアックス コーポレーション | ポリペグ化されたプロテアーゼインヒビター |
| US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
| US7276480B1 (en) | 2005-12-30 | 2007-10-02 | Dyax Corp. | Prevention and reduction of blood loss |
| CA2643693A1 (en) * | 2006-03-10 | 2007-09-20 | Dyax Corp. | Formulations for ecallantide |
| SI2379096T1 (sl) | 2008-12-19 | 2020-03-31 | Baxalta GmbH | Zaviralci TFPI in postopki uporabe |
| CN102307594A (zh) | 2009-01-06 | 2012-01-04 | 戴埃克斯有限公司 | 用激肽释放酶抑制剂治疗粘膜炎 |
| CN101798346B (zh) * | 2009-02-06 | 2013-05-29 | 复旦大学 | 一种酵母表达的长效重组人组织因子途径抑制物 |
| EP4011917A1 (en) | 2010-01-06 | 2022-06-15 | Takeda Pharmaceutical Company Limited | Plasma kallikrein binding proteins |
| BR112012023559A2 (pt) | 2010-03-19 | 2017-10-17 | Baxter Healthcare Sa | inibidores tfpi e métodos de uso |
| US8816055B2 (en) | 2011-01-06 | 2014-08-26 | Dyax Corp. | Plasma kallikrein binding proteins |
| KR101391988B1 (ko) | 2011-11-04 | 2014-05-08 | 동아대학교 산학협력단 | 항섬유소용해 기능을 가진 호박벌 독액의 쿠니츠 타입 세린 프로테아제 저해 폴리펩티드 및 이를 코딩하는 염기서열 |
| KR102263685B1 (ko) | 2012-03-21 | 2021-06-11 | 다케다 야쿠힌 고교 가부시키가이샤 | Tfpi 저해제 및 사용 방법 |
| US10428158B2 (en) | 2014-03-27 | 2019-10-01 | Dyax Corp. | Compositions and methods for treatment of diabetic macular edema |
| EA201891388A1 (ru) | 2015-12-11 | 2018-11-30 | Дайэкс Корп. | Ингибиторы калликреина плазмы и их применение для лечения обострения наследственного ангионевротического отека |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5106833A (en) * | 1987-07-23 | 1992-04-21 | Washington University | Coagulation inhibitors |
| DK408089D0 (da) * | 1989-08-18 | 1989-08-18 | Novo Nordisk As | Proteiner |
-
1993
- 1993-01-06 IL IL10432593A patent/IL104325A/xx not_active IP Right Cessation
- 1993-01-07 AU AU33459/93A patent/AU676145B2/en not_active Ceased
- 1993-01-07 ES ES93902105T patent/ES2104121T3/es not_active Expired - Lifetime
- 1993-01-07 JP JP51199293A patent/JP3350549B2/ja not_active Expired - Fee Related
- 1993-01-07 HU HU9401991A patent/HU218104B/hu not_active IP Right Cessation
- 1993-01-07 PL PL93304468A patent/PL175422B1/pl unknown
- 1993-01-07 KR KR1019940702351A patent/KR100278036B1/ko not_active Expired - Fee Related
- 1993-01-07 AT AT93902105T patent/ATE154938T1/de not_active IP Right Cessation
- 1993-01-07 CZ CZ941649A patent/CZ284911B6/cs not_active IP Right Cessation
- 1993-01-07 FI FI943233A patent/FI943233A7/fi unknown
- 1993-01-07 NZ NZ246569A patent/NZ246569A/en unknown
- 1993-01-07 WO PCT/DK1993/000004 patent/WO1993014121A1/en active IP Right Grant
- 1993-01-07 CA CA002127249A patent/CA2127249A1/en not_active Abandoned
- 1993-01-07 ZA ZA9395A patent/ZA9395B/xx unknown
- 1993-01-07 EP EP93902105A patent/EP0621871B1/en not_active Expired - Lifetime
- 1993-01-07 DE DE69311893T patent/DE69311893T2/de not_active Expired - Fee Related
-
1994
- 1994-07-06 NO NO942550A patent/NO942550L/no not_active Application Discontinuation
- 1994-10-12 US US08/321,658 patent/US5576294A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ZA9395B (en) | 1993-08-20 |
| ATE154938T1 (de) | 1997-07-15 |
| FI943233A0 (fi) | 1994-07-06 |
| HU9401991D0 (en) | 1994-09-28 |
| EP0621871B1 (en) | 1997-07-02 |
| JPH07506335A (ja) | 1995-07-13 |
| CA2127249A1 (en) | 1993-07-22 |
| NZ246569A (en) | 1996-05-28 |
| KR940703854A (ko) | 1994-12-12 |
| KR100278036B1 (ko) | 2001-01-15 |
| NO942550D0 (no) | 1994-07-06 |
| CZ284911B6 (cs) | 1999-04-14 |
| IL104325A0 (en) | 1993-05-13 |
| DE69311893T2 (de) | 1998-02-05 |
| DE69311893D1 (de) | 1997-08-07 |
| JP3350549B2 (ja) | 2002-11-25 |
| HUT70295A (en) | 1995-09-28 |
| AU3345993A (en) | 1993-08-03 |
| IL104325A (en) | 2000-10-31 |
| AU676145B2 (en) | 1997-03-06 |
| CZ164994A3 (en) | 1994-12-15 |
| EP0621871A1 (en) | 1994-11-02 |
| PL175422B1 (pl) | 1998-12-31 |
| US5576294A (en) | 1996-11-19 |
| ES2104121T3 (es) | 1997-10-01 |
| FI943233L (fi) | 1994-07-06 |
| HU218104B (hu) | 2000-06-28 |
| WO1993014121A1 (en) | 1993-07-22 |
| FI943233A7 (fi) | 1994-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO942550L (no) | Humanproteaseinhibitorvariant av Kunitz-type | |
| NO942549L (no) | Humanproteaseinhibitorvariant av Kunitz-type | |
| NO942551L (no) | Humanproteaseinhibitorvariant av Kunitz-type | |
| NO942552L (no) | Humanproteaseinhibitorvarianter av Kunitz-type | |
| EP1531791A4 (en) | PREVENTION AND REDUCTION OF BLOOD LOSS | |
| NO942553L (no) | Ny humanproteaseinhibitor av Kunitz-type og varianter derav | |
| RO91186B (ro) | Procedeu pentru prepararea unor peptide cu actiune asupra functiei glandei pituitare | |
| AR002024A1 (es) | Proteinas utiles para el tratamiento de la obesidad, composiciones farmaceuticas que incluyen dichas proteinas para tratamientos anti-obesidady procedimiento para prepararlas. | |
| AP2000001905A0 (en) | Peptide compositions and formulations and use of same. | |
| EE9600175A (et) | Kopsusurfaktandi valgu SP-C sünteetilised peptiidanaloogid | |
| DE59007517D1 (de) | Neue proteine mit tnf-hemmender wirkung und ihre herstellung. | |
| ES2112258T3 (es) | Gen y proteina precursora del cnp porcino. | |
| CA2196308A1 (en) | Peptide, bronchodilator and blood flow ameliorant | |
| PT789761E (pt) | Scf humano, uma respectiva variante de processamento, sua utilizacao farmaceutica | |
| ES2119746T3 (es) | Nuevo peptido fisiologicamente activo y agente regulador del metabolismo del calcio que comprende dicho peptido como ingrediente activo. | |
| DE60038310D1 (de) | Menschliche antithrombin-varianten | |
| RU94036770A (ru) | Домен ингибитора протеазы, днк, вектор, клетка, способ получения домена, фармацевтическая композиция, применение домена | |
| CY1115911T1 (el) | Τροποποιημενα πολυπεπτιδια περιοχης kunitz και η χρηση τους στην μειωση της ισχαιμιας ή της εκκινησης μιας συστημικης φλεγμονωδους ανταποκρισης που σχετιζεται με μια χειρουργικη επεμβαση | |
| FR2787454B1 (fr) | Inhibiteur de la topoisomerase ii | |
| TH56074A3 (th) | ตัวยับยั้ง อัลฟาv เบตา6 อินทีกริน | |
| TH34900A (th) | โปรตีนยับยั้งความอ้วน |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |